Interleukin-6 in relation to other proinflammatory cytokines, chemotactic activity and neutrophil activation in rheumatoid synovial fluid.
about
Clinical significance of interleukin-6 measurement in early rheumatoid arthritis: relation with laboratory and clinical variables and radiological progression in a three year prospective study.Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis.Progress in the use of biochemical and biological markers for evaluation of rheumatoid arthritis.The therapeutic potential of interleukin-6 hyperagonists and antagonists.The timing of glucocorticoid administration in rheumatoid arthritis.Anti-Inflammatory Effects and Joint Protection in Collagen-Induced Arthritis after Treatment with IQ-1S, a Selective c-Jun N-Terminal Kinase Inhibitor.Involvement of IL-6, apart from its role in immunity, in mediating a chronic response during experimental arthritisShuangtengbitong tincture treatment of collagen-induced arthritis via downregulation of the expression of IL-6, IL-8, TNF-α and NF-κB.Effects of RWJ 67657, a p38 mitogen activated protein kinase (MAPK) inhibitor, on the production of inflammatory mediators by rheumatoid synovial fibroblasts.Constitutive transcription of the human interleukin-6 gene by rheumatoid synoviocytes: spontaneous activation of NF-kappaB and CBF1.Transcriptional roles of CCAAT/enhancer binding protein-beta, nuclear factor-kappaB, and C-promoter binding factor 1 in interleukin (IL)-1beta-induced IL-6 synthesis by human rheumatoid fibroblast-like synoviocytes.Interleukin-6 reduces cartilage destruction during experimental arthritis. A study in interleukin-6-deficient mice.Macrophage-neutrophil interaction: a paradigm for chronic inflammation revisited.Role of Perivascular Adipose Tissue in Health and Disease.
P2860
Q33578257-013BAAFF-830E-4041-853E-3E296C83DF3FQ34084020-E23A0A82-E545-410F-AB83-28D2DDE81FD8Q34118568-1321E024-2B4D-4AF1-B28B-620CAE529EBEQ34430168-0E5AB162-B8B9-49FB-B18E-21F63E2693BFQ35546903-7DCB87B4-C913-493A-BE9D-28D4D60E0C2AQ35600218-069203E0-30C5-48DF-AB75-5046491F1E35Q35829699-5E95CA04-2289-4051-91EF-6136B2434BA7Q36603696-05CC3208-EA3E-45D9-9DDF-2523DE069BB6Q41879329-3D88237D-D8B1-4561-8364-4689BCD4FFB1Q42049241-3CAAF2D2-A3A1-41DA-8367-40D2A32B21B0Q42452643-A5FF4C2A-EC2E-4A49-B822-C660291E14FAQ42840040-3B06CD5D-7519-4867-A345-B1925F1524C8Q43742836-6D5C89C7-8CE9-4FE0-9C9C-17AED3DDC204Q52709060-5E92671D-7AC9-44AB-8143-0DADCAB5AAEB
P2860
Interleukin-6 in relation to other proinflammatory cytokines, chemotactic activity and neutrophil activation in rheumatoid synovial fluid.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Interleukin-6 in relation to o ...... in rheumatoid synovial fluid.
@en
type
label
Interleukin-6 in relation to o ...... in rheumatoid synovial fluid.
@en
prefLabel
Interleukin-6 in relation to o ...... in rheumatoid synovial fluid.
@en
P2093
P2860
P356
P1476
Interleukin-6 in relation to o ...... in rheumatoid synovial fluid.
@en
P2093
Limburg PC
van Leeuwen MA
van Riel PL
van Rijswijk MH
P2860
P356
10.1136/ARD.54.1.33
P407
P577
1995-01-01T00:00:00Z